Roche Holding AG
Roche Holding AG (RHHBY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RHHBY · as of Jun 9, 2026
Key Statistics
Explore Roche Holding AG Data
rhhby stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 33.3%
The RHHBY analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $57.00, representing +12.76% upside from the current price of $50.55.
Competitors & Peers
rhhby competitorsRHHBY
AZNCF
CHGCF
CHGCY
DSKYF
DSNKYStock Performance
Full HistoryAbout Roche Holding AG
Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors. The company boasts an extensive international …
what is roche holding ag · rhhby stock overview · roche holding ag company profile · who is roche holding ag ceo · rhhby OTC · roche holding ag headquarters · roche holding ag business segments
About Stock Overview & Key Data
Roche Holding AG (RHHBY) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Aug 20, 2003. As of the latest trading session, RHHBY stock price is $50.55, with a market capitalization of $325.6B. The stock has returned +26.02% over the past 12 months and -0.17% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Roche Holding AG stock is Hold, with an average 12-month price target of $57.00. In fiscal year 2025, Roche Holding AG reported revenue of $63.4B and net income of $12.9B. For detailed data — including Roche Holding AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Roche Holding AG (RHHBY) stock price is $50.55. The stock is traded on OTC under the ticker symbol RHHBY. The 52-week range is $37.51 – $60.85.